Abstract
Parkinson's disease is a common neurological condition, affecting approximately one in 500 individuals in the UK (Parkinson's Disease Society, 2006). Symptoms are caused by damage to and loss of the dopamine secreting cells in the substantia nigra, within the basal ganglia. Nocturia and urinary incontinence symptoms have been shown to affect 30–70% of patients with Parkinson's disease and may be exacerbated by high dose levodopa treatment (Chaudhuri, 2003). These symptoms may be compounded by bradykinesia and difficulty getting out of bed and mobilising at night, contributing to sleep disruption for patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
